multivalent scFV-Fc DNA-encoded mAbs (Inovio Pharmaceuticals/Wistar Institute)

N/A

Report date: 2025/03/20 15:02:09

Base Information

Drug Namemultivalent scFV-Fc DNA-encoded mAbs (Inovio Pharmaceuticals/Wistar Institute)
Drug Alias NameD-dMAb1-scZ/D-dMAb1-scZ-dMAb1-sc
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody +[5] 
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsZika Virus InfectionDengue
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInovio Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesInovio Pharmaceuticals IncThe Wistar Institute Of Anatomy And Biology
Inactive CompaniesN/A
Active IndicationsDengue
Inactive IndicationsZika Virus Infection

Other Information

ATC CodeN/A
Related LinksN/A